Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 6,087 | 5,594 | 7,354 | 6,558 | 6,374 |
| Operating Income | -6,087 | -5,594 | -7,354 | -6,558 | -6,374 |
| Interest Expense | 95 | 121 | 145 | 169 | 199 |
| Other Income | 1 | 1 | -2 | -5 | -1 |
| Pre-tax Income | -6,181 | -5,714 | -7,501 | -6,732 | -6,573 |
| Net Income Continuous | -6,181 | -5,714 | -7,501 | -6,732 | -6,573 |
| Net Income | $-6,181 | $-5,714 | $-7,501 | $-6,732 | $-6,573 |
| EPS Basic Total Ops | -403.96 | -0.08 | -0.11 | -0.10 | -6.67 |
| EPS Basic Continuous Ops | -403.95 | -0.08 | -0.11 | -0.10 | -6.66 |
| EPS Diluted Total Ops | -403.96 | -0.08 | -0.11 | -0.10 | -6.67 |
| EPS Diluted Continuous Ops | -403.95 | -0.08 | -0.11 | -0.10 | -6.66 |
| EBITDA(a) | $-6,017 | $-5,519 | $-7,274 | $-6,473 | $-6,280 |